Lundbeck research director denies money-saving exercise: "We are having a clear out of old biology"
Lundbeck's plan to cut 130-160 positions at the research and development department is not about saving money, says research director Johan Luthman. Instead, it is about focusing on new drug classes and disease areas.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY CATHERINE BRETT
Johan Luthman, the Lundbeck group research and development director, understands that it seems strange when the company uses the same press release to announce that they are cutting more than 100 positions in his department, and that they want to strengthen the department.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
